Chronic HIV Infection, Immune Pathogenesis and Therapy

A Special Issue of Microorganisms (ISSN 2076-2607) belonging to the section "Molecular Microbiology and Immunology".

Deadline for manuscript submissions: 31 January 2027 | Viewed by 255

Editor


E-Mail Website
Guest Editor
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
Interests: HIV-1; plasmacytoid dendritic cells; immunopathology; immunotherapy; humanized mice; CAR-T

Special Issue Information

Dear Colleagues,

Despite effective suppression of HIV-1 replication and increased survival with HAART, HIV-1 rebounds in all patients post-HAART cessation due to “HIV-1 viral reservoir” cells with latent or low-replicating HIV infection in lymphoid tissues. In addition, some HAART-treated patients fail to reverse hyper-inflammatory activation and achieve full immune recovery.

Fully understanding how HIV reservoirs and chronic inflammation persist during HAART and elucidating the mechanism underlying “immune nonresponder (INR)” patients will aid the development of novel therapeutics for chronic HIV-1 infection-associated diseases, approaching a functional or sterilizing cure of HIV-1 infection.

This Special Issue welcomes research articles (1) providing new knowledge related to HIV-1 infection/replication, HIV reservoir persistence, residual chronic inflammation, and impaired host immunity during HAART and (2) offering novel approaches to control HIV-1 infection/replication, further eliminate viral reservoirs, resolve chronic inflammation, and recover/enhance host immune response during HAART.

Dr. Guangming Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HIV-1
  • HAART
  • reservoir
  • inflammation
  • host immunity
  • therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop